Insider Cluster (2 insiders) ·Filed Jul 24, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $557K total
Actionable Insight • Neutral

The insider sales are routine and proportional to the CEO's option exercises — no bearish signal. Monitor UTHR's upcoming earnings for any guidance changes, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
UTHR ▼ -3.34% at T+20d
NEUTRAL call ✗ call lost -3.34% · α vs SPY -6.96% · entry $528.47 → $510.82
Next anchor: T+60d in 14d
Latest observation: T+47 +9.37% FF3 residual α
Entry anchored
Jul 23, 03:59 PM ET
via exchange tick
T+1d
-0.10%
call -0.10% · α -0.12%
$527.94
settled 2mo ago
T+5d
-0.50%
call -0.50% · α -0.88%
$525.82
settled 2mo ago
T+20d
-3.34%
call -3.34% · α -6.96%
$510.82
settled 6w ago
T+60d
—
call — · α —
—
in 14d

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt sold $6.3M in open-market shares over two days (July 22-23), primarily to cover taxes on exercised options, while EVP Paul Mahon sold $426K on July 16. The CEO's sales are largely routine tax-withholding transactions tied to derivative exercises, but the total open-market sale value of ~$6.3M represents ~0.03% of UTHR's $22.5B market cap — well below the 0.1% materiality threshold. This cluster is not actionable given the trivial proportionality and the liquidity-driven nature of the sales.

Key Financial Metrics

Direction
selling
Total Value
$6.7M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$6.3M in open-market shares on July 22-23, primarily to cover taxes on exercised options (9,500 shares exercised at $0 and $135.42).
  • EVP Paul Mahon sold 800 shares for $426K on July 16.
  • Total open-market sales of ~$6.7M represent ~0.03% of UTHR's $22.5B market cap — trivial and routine.
  • Director Ray Kurzweil received a non-cash grant of 1,190 shares on July 22.
  • The cluster is dominated by the CEO's tax-motivated sales following option exercises, not a coordinated bearish signal.

Financial Impact

Total open-market sales of ~$6.7M, or ~0.03% of market cap — immaterial.

dilution

Risk Factors

  • CEO selling is always optically negative, but the dollar amount is trivial relative to market cap.
  • No material risk from this cluster — sales are tax-driven and non-informative.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784952142658
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 25, 2026